Pharmacotherapy of alcohol use disorders (Q36311029)

13 August 2017

1 reference

title

Pharmacotherapy of alcohol use disorders (English)

1 reference

13 August 2017

0 references

0 references

Alessandra Buonopane

1

1 reference

13 August 2017

Ismene L Petrakis

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

published in

Substance Use and Misuse

1 reference

13 August 2017

volume

40

1 reference

13 August 2017

issue

13-14

1 reference

13 August 2017

page(s)

2001-20, 2043-8

1 reference

Combining ondansetron and naltrexone reduces craving among biologically predisposed alcoholics: preliminary clinical evidence

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Effectiveness Of Substance Abuse Treatment Programming For Women: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Inhibition of elimination of caffeine by disulfiram in normal subjects and recovering alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Maintaining disulfiram ingestion among outpatient alcoholics: a security-deposit contingency contracting procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Alcohol promotes dopamine release in the human nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The use of divalproex in alcohol relapse prevention: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Delirium with phenytoin and disulfiram administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Safety issues concerning the use of disulfiram in treating alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Gender effects on the clinical presentation of alcoholics at a psychiatric hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The safety profile of naltrexone in the treatment of alcoholism. Results from a multicenter usage study. The Naltrexone Usage Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Subgroup variation in U.S. drinking patterns: results of the 1992 national longitudinal alcohol epidemiologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Naltrexone treatment for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Disulfiram treatment of alcoholism. A Veterans Administration cooperative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Pharmacological treatment of alcohol dependence: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Central Deficiency of β-Endorphin in Alcohol Addicts*

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Implication of the endogenous opioid system in excessive ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Characterization of the ethanol-like discriminative stimulus effects of 5-HT receptor agonists as a function of ethanol training dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Testing combined pharmacotherapies and behavioral interventions for alcohol dependence (the COMBINE study): a pilot feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Olanzapine reduces urge to drink after drinking cues and a priming dose of alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Gabapentin treatment for insomnia associated with alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Spouse contracting to increase antabuse compliance in alcoholic veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Introduction: natural recovery research across substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Cellular and molecular mechanisms of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Disulfiram treatment of patients with both alcohol dependence and other psychiatric disorders: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Dose-dependent inhibition of theophylline metabolism by disulfiram in recovering alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Interaction of disulfiram with benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The effects of carbamazepine and lorazepam on single versus multiple previous alcohol withdrawals in an outpatient randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Do women develop alcoholic brain damage more readily than men?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Physicians’ opinions about medications to treat alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Amisulpride does not prevent relapse in primary alcohol dependence: results of a pilot randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Disulfiram effects on acute cocaine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Naltrexone for alcohol dependence: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

A double-blind, placebo-controlled pilot study of carbamazepine for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Oxcarbazepine for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Antabuse contracts for married alcoholics and their spouses: a method to maintain antabuse ingestion and decrease conflict about drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Effect of tryptophan depletion on alcohol cue-induced craving in abstinent alcoholic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Dextromethorphan challenge in alcohol-dependent patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Tiapride in the long-term management of alcoholics of anxious or depressive temperament

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Narcotic withdrawal syndrome caused by naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Pharmacokinetic interactions between theophylline and other medication (Part I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Dual diagnosis in primary care. Detecting and treating both the addiction and mental illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

The glutamatergic basis of human alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10826080500294890

10.1080/10826080500294890

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference